2008; 25:457–507.. Guidelines for the management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis
2006; 22:294–316.. Recommendations for the Management of Intracranial Haemorrhage – Part 1: Spontaneous Intracerebral Haemorrhage. Cerebrovasc Dis
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274(13): 1017–25., et al.
1995; 333:1581–8.. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med
Randomised double-blind placebo controlled trial of thrombolytic therapy with intravenous Alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352:1245–51., et al.
Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a Randomized Controlled Trial. JAMA 1999; 282(21):2019–26., et al.
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stroke trials. Lancet 2004; 363:768–74., et al.
Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007; 38(8):2275–8., et al.
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006; 77(7):826–9., et al.
Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37(2):425–9., et al.
Thrombolysis with Alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275–82., et al.
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke 2005; 36(7):1432–8., et al.
1994; 308(6921):81–106.. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ
1997; 349:1569–81.. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet
1997; 349:1641–9.. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet
What is the best imaging strategy for acute stroke?Health Technol Assess 2004; 8:1–180., et al.
2002; 324(7329):71–86.. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ
2006; 367:1665–73.. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359(12):1238–51., et al.
Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial. Circulation 2005; 111(17):2233–40., et al.
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364:331–37., et al.
2004; CD000024., , . Anticoagulants for acute ischaemic stroke. Cochrane Database of Systematic Reviews
Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 2007; 38(2):423–30., et al.
NXY-059 for the treatment of acute ischaemic stroke. N Engl J Med 2007; 357:562–71., et al.
Control of hypertension and risk of stroke recurrence. Stroke 2002; 33(11):2652–7., , .
Blood pressure in acute stroke. Age Ageing 2004; 33:6–12., .
Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33:1315–20., et al.
Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 1998; 29:1504–9., et al.
International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21:665–72., et al.
Blood pressure decrease during the acute phase of ischaemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004; 35:520–7., et al.
Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003; 61:1047–51., et al.
High blood pressure in acute stroke and subsequent outcome. A systemic review. Hypertension 2004; 43:18–24., , .
Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2002; 72:467–72., et al.
Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993; 43:461–7..
Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005; 36:264–9., et al.
Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007; 38:961–6., et al.
2005. http://www.le.ac.uk/cv/research/COSSACS/COSSACShome.html [cited 18 June 2005]..
2001; Issue 3. CD000039. DOI 10.1002/114651858.CD000039.. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews,
Treatment of post-stroke hypertension. A practical guide. Drugs Aging 1996; 8(6):408–15., .
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38(5):1655–711., et al.
Stress hyperglycaemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:2426–32., et al.
Glucose and insulin therapy in acute stroke; why delay further?Q J Med 1998; 91:511–15., et al.
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 1997; 314:1303–6., et al.
Randomised trial of insulin glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction. The DIGAMI Study. J Am Coll Cardiol 1995; 26:57–65., et al.
Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359–67., et al.
Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6:397–406., et al.
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6:215–22., et al.
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7(5):391–9., et al.
International Stroke Conference, New Orleans, LA, USA. 2008.. Antihypertensive treatment of acute cerebral haemorrhage (ATACH). In
Antithrombotic and antithrombolytic therapy for ischaemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:483S–512S., et al.
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365(9457):387–97., et al.
Recombinant activated Factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352(8):777–85., et al.
Efficacy and safety of recombinant activated Factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358(20):2127–37., et al.
2008; 372(9646):1303–9., et al. for the SITS investigators. Thrombolysis with alteplase 3 to 4.5 h after acute ischaemic stroke in the Safe Implementation of Treatments in Stroke Register (SITS-ISTR): an observational study. Lancet
for the European Cooperative Acute Stroke Study (ECASS) investigators. Alteplase compared with placebo within 3 to 4.5 hours for acute ischemic stroke. N Engl J Med 2008; 359:1317–29., et al.